OPRX
insider transactionsOptimizeRx Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
17.3K sh
Own +132%
-
Grant·A
Director
$0
34.5K sh
Own +78%
-
Grant·A
Director
$0
34.5K sh
Own +48%
-
Grant·A
Director
$0
34.5K sh
Own +60%
-
Grant·A
Director
$0
34.5K sh
Own +9%
-
Grant·A
Director
$0
34.5K sh
Own +160%
-
Other·F
Chief Executive Officer
$27.2K
5.2K sh · $5.21
Own -3%
-
Other·F
Chief Commercial Officer
$4.6K
879 sh · $5.21
Own -1%
-
Other·F
Chief Commercial Officer
$4.8K
914 sh · $5.21
Own -1%
-
Grant·A
Director
$0
13.1K sh
Own New
-
Exercise·M
Chief Legal & Admin Officer
$0
4.0K sh
Own New
-
Other·F
Chief Legal & Admin Officer
$12.8K
1.4K sh · $9.23
Own -1%
-
Exercise·M
Chief Legal & Admin Officer
—
4.0K sh
Own +4%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 9, 2026 | Mariyamma Varghese Presti | Grant A | 17.3K | $0 |
| Jun 9, 2026 | Patrick D Spangler | Grant A | 34.5K | $0 |
| Jun 9, 2026 | Ellen O'Connor Vos | Grant A | 34.5K | $0 |
| Jun 9, 2026 | Gregory D Wasson | Grant A | 34.5K | $0 |
| Jun 9, 2026 | James Paul Lang | Grant A | 34.5K | $0 |
| Jun 9, 2026 | Cathy Klema | Grant A | 34.5K | $0 |
| May 15, 2026 | Stephen L Silvestro KEY | Other F | 5.2K | $27.2K |
| May 15, 2026 | Theresa Greco | Other F | 879 | $4.6K |
| May 15, 2026 | Theresa Greco | Other F | 914 | $4.8K |
| May 1, 2026 | Mariyamma Varghese Presti | Grant A | 13.1K | $0 |
| Feb 11, 2026 | Marion Odence-Ford | Exercise M | 4.0K | $0 |
| Feb 11, 2026 | Marion Odence-Ford | Other F | 1.4K | $12.8K |
| Feb 11, 2026 | Marion Odence-Ford | Exercise M | 4.0K | — |
About OPRX insider trading
This page tracks insider transactions for OptimizeRx Corp (OPRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.